CONTACT: L. E. OHMAN
2130 Medical Laboratories
Iowa City IA 52242
(319) 335-6660; fax (319) 335-8034
Volunteers sought for study with LDL-cholesterol lowering drug
IOWA CITY, Iowa -- The University of Iowa is one of 250 medical centers
participating in an international study to determine if lowering LDL-cholesterol
(bad cholesterol) beyond the current recommended level will decrease further
heart problems in patients with known heart disease.
Participants in the study will be treated with the FDA-approved cholesterol-lowering
drug Lipitor, also known as atorvastatin.
"We look forward to being a part of this important study,"
said Dr. Helmut Schrott, UI lead investigator and associate professor of
preventive medicine and environmental health. "We are studying whether
lowering LDL-cholesterol beyond current standards will achieve greater
Adults ages 35-75 who have experienced a heart attack, chest pain or
heart-related surgery in the past five years may be eligible to participate
in this five-year study.
Qualified people will receive medical monitoring including: annual physical
with EKG, blood and lab evaluations and nutrition counseling, as well as
medication to lower blood cholesterol.
If you are eligible and are interested in participating in the study,
call the UI Lipid Research Clinic, (319) 335-6677 or 1-800-887-6917.